Skip to main content
Journal cover image

Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus.

Publication ,  Journal Article
Brown, DS; Johnson, FR; Poulos, C; Messonnier, ML
Published in: Vaccine
February 17, 2010

A choice-format, conjoint-analysis survey was developed and fielded to estimate how features of human papillomavirus (HPV) vaccines affect mothers' perceived benefit and stated vaccine uptake for daughters. Data were collected from a national sample of 307 U.S. mothers of girls aged 13-17 years who had not yet received an HPV vaccine. Preferences for four features of HPV vaccines were evaluated: protection against cervical cancer, protection against genital warts, duration of protection, and cost. We estimate that mean maximum willingness-to-pay (WTP)-an economic measure of the total benefits to consumers-for current HPV vaccine technology ranges between $560 and $660. All vaccine features were statistically significant determinants of WTP and uptake. Mothers were willing to pay $238 more for a vaccine that provides 90% protection for genital warts relative to a vaccine that provides no protection against warts. WTP for lifetime protection vs. 10 years protection was $245. Mothers strongly valued greater cervical cancer efficacy, with 100% protection against cervical cancers the most desired feature overall. Adding a second HPV vaccine choice to U.S. consumers' alternatives is predicted to increase stated uptake by 16%. Several features were significantly associated with stated choices and uptake: age of mother, race/ethnicity, household income, and concern about HPV risks. These findings provide new data on how HPV vaccines are viewed and valued by mothers, and how uptake may change in the context of evolving vaccine technology and as new data are reported on duration and efficacy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Vaccine

DOI

EISSN

1873-2518

Publication Date

February 17, 2010

Volume

28

Issue

7

Start / End Page

1702 / 1708

Location

Netherlands

Related Subject Headings

  • Virology
  • Uterine Cervical Neoplasms
  • United States
  • Papillomavirus Vaccines
  • Papillomavirus Infections
  • Nuclear Family
  • Mothers
  • Middle Aged
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Brown, D. S., Johnson, F. R., Poulos, C., & Messonnier, M. L. (2010). Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus. Vaccine, 28(7), 1702–1708. https://doi.org/10.1016/j.vaccine.2009.12.024
Brown, Derek S., F Reed Johnson, Christine Poulos, and Mark L. Messonnier. “Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus.Vaccine 28, no. 7 (February 17, 2010): 1702–8. https://doi.org/10.1016/j.vaccine.2009.12.024.
Brown DS, Johnson FR, Poulos C, Messonnier ML. Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus. Vaccine. 2010 Feb 17;28(7):1702–8.
Brown, Derek S., et al. “Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus.Vaccine, vol. 28, no. 7, Feb. 2010, pp. 1702–08. Pubmed, doi:10.1016/j.vaccine.2009.12.024.
Brown DS, Johnson FR, Poulos C, Messonnier ML. Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus. Vaccine. 2010 Feb 17;28(7):1702–1708.
Journal cover image

Published In

Vaccine

DOI

EISSN

1873-2518

Publication Date

February 17, 2010

Volume

28

Issue

7

Start / End Page

1702 / 1708

Location

Netherlands

Related Subject Headings

  • Virology
  • Uterine Cervical Neoplasms
  • United States
  • Papillomavirus Vaccines
  • Papillomavirus Infections
  • Nuclear Family
  • Mothers
  • Middle Aged
  • Humans
  • Female